ArticleSurgical endoscopy2026
Indocyanine green fluorescence navigation versus conventional laparoscopic hepatectomy for hepatic hemangioma: a propensity score matched study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndocyanine Green (ICG) fluorescence navigation is increasingly used in laparoscopic liver surgeries, yet its benefits for hepatic hemangioma resection remain unclear. This study assessed the effectiveness and clinical value of ICG fluorescence navigation laparoscopic hepatectomy for hepatic hemangioma, compared with the conventional laparoscopic resection.
methodsWe retrospectively analyzed a cohort of hepatic hemangioma patients who underwent laparoscopic hepatectomy at West China Hospital of Sichuan University from May 2015 to April 2024. Propensity score matching (PSM) was utilized to match patients undergoing ICG fluorescence navigation laparoscopic hepatectomy (ICG-LH) with those undergoing conventional laparoscopic hepatectomy (LH) in a 1:3 ratio to minimize the influence of confounding factors. We compared perioperative variables between the two groups to ascertain the superior method for hepatic hemangioma hepatectomy.
resultsICG-LH demonstrated superior perioperative outcomes (median blood loss: 100 ml vs 200 ml, p < 0.001; hospitalization: 5.9 days vs 7.1 days, p < 0.001). Albumin levels on postoperative day 1 and day 3 were found to be significantly higher in the ICG-LH compared to the LH group (p < 0.05). Subgroup analyses based on IWATE criteria revealed that, in patients with an IWATE score greater than 9, compared to the LH group patients, ICG-LH patients exhibited shorter operative time (158.3 min vs 224.4 min, p < 0.001), significantly reduced blood loss (100 ml vs 500 ml, p = 0.001), decreased number of hepatic inflow occlusions (1.5 times vs 3 times, p = 0.002), and a reduction in the total duration of hepatic inflow occlusion (35 min vs 55 min, p = 0.004).
conclusionsThe comparative analysis revealed the advantages of ICG-LH over conventional LH approaches for hepatic hemangioma resection, demonstrating its enhanced perioperative performance metrics, and may potentially optimize postoperative functional recovery while reducing procedure-related morbidity.
Indexed as
Identifiers
41068415What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.